Objectives: To conduct a systematic review to determine whether there is an association between metabolic syndrome (MetS) and lower urinary tract symptoms (LUTS) or overactive bladder (OAB) in women. Methods: We systematically reviewed English language observational studies on the effect of MetS (or component factors) on the presence of OAB or LUTS in women. We searched PubMed, Web of Science and The Cochrane Library with no date restrictions, checked reference lists and undertook citation searches in PubMed and Google Scholar. Studies were assessed for risk of bias. Because of heterogeneity, results were not pooled, but are reported narratively. Results: Of 27 included studies, only three looked at the link between MetS and OAB. The rest looked at links between OAB and components of MetS such as obesity or insulin resistance (n = 10), between MetS and urinary symptoms (n = 3) and between urinary symptoms and components of MetS, such as obesity (n = 14). Evidence is currently limited, but it does suggest that there may be important links between MetS and OAB and components of MetS such as obesity. Conclusions: The literature on MetS and OAB or LUTS in women is limited, and poor quality. However, the evidence available on obesity appears to support MetS as a contributor and predictor of LUTS in women. Many of the women with LUTS will be overweight and will have features of the MetS, if looked for. This provides not only an opportunity to encourage weight loss as an adjunct to therapy for the OAB symptoms but also a window of opportunity to address cardiovascular risk factors and prevent future cardiovascular morbidity and mortality.
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Review criteria
Observational studies examining the link between metabolic syndrome (MetS) (or components of MetS) and the presence of OAB or LUTS were identified through database and lateral searches.
Message for the clinic
Both obesity and MetS have been shown to have complex links with LUTS. It is not known whether reducing insulin resistance and central obesity-related chronic inflammation and oxidative stress might prevent the onset of OAB or improve the outcome of current treatment. However, identifying women with MetS who harbour a portfolio of cardiovascular risk factors does provide an opportunity to address future cardiovascular risk, and prevent premature morbidity and mortality; although whether this will have an effect on the storage component of LUTS is unclear. The key variables to address are diet and lifestyle, especially exercise. The investigations should include a blood pressure recording, BMI and waist circumference measurement together with a lipid profile and HbA1c. These results should be transmitted to the GP for action.
Background

Introduction to overactive bladder
Lower urinary tract symptoms (LUTS) is now thought of as an umbrella term, encompassing all disorders of bladder and urethral function (1), including storage, voiding and postmicturition symptoms (2) . Storage symptoms are often more stressful and bothersome than voiding symptoms; especially if incontinence features as a symptom (3) . The prevalence of LUTS in women has been found to be high, with 76% of women aged between 40 and 99 years reporting that they sometimes had LUTS and 53% that they often did (4) .
The term overactive bladder (OAB) is used to describe storage symptoms excluding stress (exertional) urinary incontinence and has been defined as a symptom complex characterised by urinary urgency, with or without urgency incontinence, usually with urinary frequency and nocturia (5) . International population-based studies have reported prevalence rates of OAB around 12% (6, 7) rising to 17% in individuals aged 40 and over (8) . Rates were similar in men and women and increased with age (6) .
The underlying pathophysiology of OAB has not been completely explained, but includes abnormalities in the detrusor muscle, whereby spontaneous motor activity may occur, and the urothelium, which can trigger urgency by neurotransmitter release and by central mechanisms, linked to cerebral white matter changes, particularly in the prefrontal regions of the brain. The urothelium/suburothelium compartment of the bladder has a high metabolic rate and is now believed to play a key role in mechanosensory transduction (9) .
What is metabolic syndrome?
The metabolic syndrome (MetS) is a common disorder, which describes the frequent clustering of several metabolic abnormalities, including central obesity, dyslipidaemia, hypertension, insulin resistance and glucose intolerance [Type 2 diabetes, impaired glucose tolerance (IGT) or impaired fasting glycaemia] (10). This combination of symptoms occurs in individuals more often than might be expected by chance alone (10) , and when grouped together are associated with increased risk of cardiovascular disease, including coronary heart disease (CHD), stroke (11, 12) and type 2 diabetes (13, 14) . In most cases, MetS is thought to develop as a result of poor eating habits and a sedentary lifestyle; and with the current global epidemic of obesity and diabetes the prevalence of MetS is growing rapidly (10), adversely affecting daily activities and general well-being (15) . In addition to general obesity, the distribution of body fat, in particular abdominal obesity, is independently associated with the MetS in older women, particularly among those of normal body weight (16) .
The World Health Organization developed the first internationally accepted definition of MetS in 1998 (17) ; since then, other organisations have proposed definitions, including the National Cholesterol Education Program's Adult Treatment Panel III Report (18) , The International Diabetes Federation (IDF; 19) and the American Heart Association and the National Heart, Lung and Blood Institutes (20) . The varying definitions (Table 1) all accept four core components of MetS -glucose intolerance, obesity, hypertension and dyslipidaemia -but differ in the specific levels set for each component and the combination of symptoms required. For example, the IDF (19) puts more emphasis on central obesity, as it is more strongly related to other MetS features than any other factor (21).
The Metabolic Syndrome and LUTS
Recently, MetS has been implicated in the aetiology of LUTS (22) and is thought to affect bladder function by its stimulating effects on the autonomic nervous system (ANS). Evidence of an association between MetS and OAB has been identified in women (23, 24) . MetS may cause OAB symptoms via a number of possible mechanisms. These include acting through the ANS either directly or by induction of diabetes and the production of pelvic ischaemia via atherosclerosis (25) .
Accumulating evidence from clinical studies and basic research suggests that ischaemia may be an independent factor in the development of nonobstructed non-neurogenic bladder overactivity and LUTS. A close correlation between pelvic ischaemia and bladder overactivity has been documented in elderly men and women (26) (27) (28) (29) . Recent research has established a link between LUTS and the MetS in men (30) , providing a rationale for the present review, which focuses on the relationship between MetS and OAB in women. The overall aim of this systematic review was to synthesise the international literature to determine whether there is an association between MetS and LUTS or OAB in women.
Methods
Inclusion criteria
We included studies pertaining to the effect of MetS on the presence of OAB or other LUTS in women. MetS was defined as: a combination, or clustering, of several metabolic abnormalities or risk factors, including (i) central obesity, (ii) dyslipidaemia, (iii) hypertension, (iv) insulin resistance with compensatory hyperinsulinaemia and (v) glucose intolerance (Type 2 diabetes, IGT, or impaired fasting glycaemia) (10) . As there are relatively few studies focusing specifically on MetS, we broadened our criteria to include related components of MetS such as abdominal obesity, insulin resistance and hyperlipidaemia. Although diabetes is also a risk factor for MetS, we excluded studies focusing on diabetes on the basis that these patients may also have neuropathy and more frequent UTIs (31, 32) .
We used the International Continence Society definition of OAB, which defines it as a symptom syndrome; characterised by urinary urgency, with or without urgency incontinence, usually with increased daytime frequency and nocturia (33) . We also included studies reporting urgency urinary incontinence (UUI) or mixed urinary incontinence (MUI), but excluded those only reporting stress urinary incontinence (SUI) as this is not associated with OAB. We also excluded studies where the type of incontinence was not specified.
We included all studies that examined an association between OAB and MetS in women. This included cross-sectional studies, cohort studies and case-control studies. Our main outcome of interest was the association between OAB and MetS, but we also looked at the association of other components of MetS (such as abdominal obesity measured by waist circumference) with OAB or urinary symptoms associated with OAB such as urgency incontinence.
Identification of studies
To identify studies for the review, we searched the following electronic databases: PubMed, Web of Science (including SCI, SSCI, HCI), Google Scholar and the Cochrane Library. In addition, we used 'lateral searching' techniques such as checking reference lists of relevant papers, and using the 'Cited by' option on Google Scholar and Scopus, and the 'Related articles' option on PubMed. Methodological search filters were not used. Searches were limited to published English language studies. There were no date restrictions. Database searches were run in August 2012 and lateral searching was updated in October 2013; search terms can be seen in Box 1.
Study screening
Electronic search results were downloaded into EndNote bibliographic software and, where possible, duplicates deleted. Title and abstracts were screened by one author with a random 10% of records independently screened by a second author to check for agreement. Full manuscripts of all potentially relevant citations were screened independently by two reviewers using a screening form with clearly defined criteria. Uncertainties were resolved by consensus or by discussion with a third reviewer.
Data extraction, critical appraisal and analysis
For studies that met the inclusion criteria, data were extracted onto a predesigned, and piloted, form. Data included the following: type of study design (e.g. cross-sectional, case-control), characteristics of participants (including age, sex, ethnicity), number of participants, country of origin, outcomes relating to MetS or OAB (including how they were measured) and estimation of association between MetS, or components of MetS, and OAB.
The methodological quality of studies was assessed using criteria based on those of the Centre for Evidence Based Management. The core quality assessment principles are summarised in Table 2 . Owing to sub- 
Results
Description of studies
Twenty-nine papers reporting 27 studies met the inclusion criteria (Table 3 ) (4, 7, 23, 24, . An overview of the selection process can be seen in Figure 1. Two studies were classified as case-control studies (24, 46) and the rest as surveys/cross-sectional studies. The number of participants in studies ranged from 60 to 27,936. Fifteen studies made a specific reference to OAB (4, 23, 24, 35, 36, 38, 40, (43) (44) (45) (46) (50) (51) (52) 55, 56) . The others categorised urinary symptoms in a variety of ways including LUTS, UUI, SUI and MUI. Details of the type of incontinence and how it was measured and classified can be seen in Table 4 .
Only four studies looked specifically at MetS (23, 40, 42, 43) . Definitions of MetS were based on criteria relating to waist circumference and levels of triglycerides, high-density lipoprotein cholesterol, blood pressure and fasting glucose. The remaining studies included information about components of MetS such as obesity, insulin resistance and dyslipidaemia. Obesity was most commonly measured using the body mass index (BMI; reported in 27 studies) but a number of studies also looked at waist circumference (reported in nine studies) or waist-hip ratio.
Study quality
Of the observational studies, 13 were judged to be free from selection bias because they involved a population-based sample or large samples from general practice or a HMO database. In seven studies, the response rate was not clear, but of the others, 11 were judged to have a satisfactory response rate (≥ 50%). Quality assessment scores can be seen in Table 5 and a summary of quality assessment domains for the 25 crosssectional studies in Figure 2 .
Findings
Three studies looked at the link between OAB and MetS, 12 the link between OAB and associated risk factors (such as obesity and hyperlipidaemia), three the association between MetS and urinary symptoms and 14 the link between UUI or MUI and components of MetS. Details of the results (including effect sizes) can be seen in Table 5 . 
MetS and overactive bladder
Of the three studies that looked at whether there appeared to be a link between OAB and MetS (23, 40, 43) , all found a significant association. However, these studies had relatively small sample sizes and none scored more than six on the quality assessment tool.
OAB and associated risk factors
Ten studies considered whether there was a link between OAB and obesity. There was a statistically significant link between obesity (as measured by BMI) and OAB in eight (4, 23, 35, 36, (44) (45) (46) 51) , although in one small study (35) , this was only significant in premenopausal women. Four of the studies that found a positive correlation had a quality assessment score of 8 or above. Of the others, one found a non-significant trend towards increasing prevalence of OAB with higher degree of obesity (55) and one (24) no significant association between OAB and BMI. Two studies found increasing odds of OAB in those with an increased waist circumference (23, 45) and another reported no significant association between OAB and waist circumference (24) . Four studies looked at the link between hyperlipidaemia and OAB; three found no significant association (23, 24, 38) and one found increased odds of OAB in those with hyperlipidaemia (56).
MetS and urinary symptoms (LUTS, urgency, frequency)
Of the three studies that examined the link between MetS and urinary symptoms (40, 42, 52) , one (52) found a possible association, one (40) a significant difference in LUTS scores in those with MetS and one an association between MetS and MUI but not UUI (42) .
Urinary symptoms (e.g. LUTS, UUI) and associated risk factors
Ten studies found an increased likelihood of urinary symptoms in those who were obese, but four did not (7, 38, 40, 48) . Of those that did find an association between urinary symptoms and increased BMI, eight reported an increase in MUI (34, 39, 41, 47, 49, 53, 54, 57) . One study (40) reported no significant correlation between levels of high-density lipoproteins (HDL) and International Prostate Symptom Score.
Discussion
We included 27 studies, but, of those, only three looked specifically at the link between MetS and OAB in women. The remaining literature evaluated the links between OAB and components of MetS such as obesity or insulin resistance (n = 10), between MetS and urinary symptoms (n = 3) and between urinary symptoms and components of MetS (n = 14). Although the evidence is currently limited, it does suggest that there may be important links between MetS and OAB and between MetS and OAB symptom complex. Several studies have demonstrated strong links between MetS and OAB in men (30, 58, 59) . OAB has also been reported to be significantly associated with an increased prevalence of erectile dysfunction (ED) in men (60, 61) and ED has been reported to be strongly related to MetS (62) . Possible common explanatory aetiological mechanisms include atherosclerotic vascular disease, decreased nitric oxide levels or nitric oxide synthase expression and alterations of calcium regulatory proteins in smooth muscle, all of which influence both bladder and penile physiology. Although the anatomy and pathophysiology in relation to obstruction and OAB symptoms are clearly different in men and women, the underlying bladder pathophysiology may share some common features.
An association between OAB and decreased sexual enjoyment in women mediated via decreased clitoral swelling, similar to ED in men, has also been reported (60) . In both sexes, changes in bladder function may relate to changes in the bladder vasculature, epithelium, neuronal supply, smooth muscle and connective tissue, leading to LUTS. In older women, LUTS questionnaire scores show similar results to those of age-matched men (63, 64) .
There are a number of reported reasons why women with MetS may be at greater risk of developing OAB. These include inflammatory sympathetic overactivity, pro-inflammatory status, oxidative stress and endothelial dysfunction in addition to ischaemic damage during bladder storage, decreased perfusion of the bladder and bladder neck, an increase in nonesterified fatty acids and a nitric oxide deficiency. OAB may result from pathological change in all layers of bladder wall, rather than just the smooth muscle (myogenic theory) or nerves (neurogenic theory) (23) . OAB is associated with impaired bladder contractility, in contrast to normal ageing, in addition to an overactivity (65) .
Insulin resistance caused by obesity is a significant component of MetS and it is argued that pro-inflammatory state, increased free fatty acids, hypercoagulability, and cellular oxidative stress lead to premature vascular disease (66) . In one study investigating this, there was a positive correlation with serum insulin levels in women with OAB. In addition, HOMA-IR, a measure of insulin resistance, was significantly higher in the OAB group in comparison to controls. HDL cholesterol levels were significantly lower in women with OAB (24) . Additionally, an epidemiological survey (67) demonstrated an association between increasing C-reactive protein, a marker of inflammation, and OAB for both men and women. An association with reduced blood flow to the bladder and LUTS in older women has also been demonstrated (26) . Many women with polycystic ovary syndrome have bladder storage symptoms and additional features of the MetS, especially insulin resistance, obesity, and a raised serum testosterone concentration. These women have a higher prevalence and a greater degree of hyperinsulinaemia (68, 69) ; as many as 30% have IGT and 7.5% have diabetes, (70) leading to increased cardiovascular risk (71) . Because the ovarian hyperandrogenism contributes to insulin resistance (72) , it may be contributing to the bladder storage symptoms in these women (73) .
Limitations
We used systematic and rigorous methods to synthesise the current evidence on the link between OAB and MetS in women. However, there are a number of methodological limitations that could have a bearing on the validity of the results. We found only three studies that looked specifically at the association of OAB and MetS; other studies looked at components of MetS (such as obesity) or urinary symptoms more generally (e.g. LUTS). In addition, the quality of the studies was mixed with none of the studies fulfilling all of the criteria on the quality assessment checklists.
Implications for practice
The evidence supporting links between the MetS and LUTS in women is weaker than in men. However, current evidence does suggest that in women presenting with OAB, consideration should be given to whether the MetS is present. Although it is not known whether reducing insulin resistance and obesity related chronic inflammation and oxidative stress might prevent the onset of OAB and reduce LUTS, identifying women with MetS provides an opportunity to address the portfolio of cardiovascular risk factors and prevent premature morbidity and mortality. Although it remains prudent to recommend weight loss in overweight and obese women, control of all modifiable cardio-metabolic risk factors in both normal and overweight persons to prevent transition to the MetS and diabetes should be considered the ultimate goal (74) .
Obesity and type 2 diabetes are particularly detrimental to women's health. Women with a higher degree of abdominal obesity are especially susceptible to type 2 diabetes, and women with diabetes have a disproportionally higher relative risk of CHD than men with diabetes (75, 76) . As the MetS may be a better predictor of future cardiovascular risk in women than the BMI, waist circumference may be a more important clinical measure than the BMI. Key variables to explore are diet and lifestyle, especially exercise routines, lipids, blood pressure and dysglycaemia. Investigations should include a blood pressure recording, BMI and waist circumference measurement together with a lipid profile and HbA1c. These results should be transmitted to the Primary Healthcare Team for action.
Conclusions
There is increasing evidence to suggest there may be a link between MetS and OAB or LUTS. There is good evidence to suggest that obesity is an important predictor of LUTS in women. Many obese women will have features of the MetS, if looked for, and this provides a window of opportunity to address cardiovascular risk factors and prevent future cardiovascular morbidity and mortality; the effect of intervention on LUTS in women is unclear.
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